EWTX financials
Edgewise Therapeutics (EWTX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
EWTX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | -$2.27M | -$191.41M | -$167.79M | -1.63 |
| 2024 | $0.00 | $0.00 | -$158.83M | -$133.81M | -1.45 |
| 2023 | $0.00 | $0.00 | -$114.36M | -$100.16M | -1.57 |
| 2022 | $0.00 | $0.00 | -$71.66M | -$67.64M | -1.26 |
| 2021 | $0.00 | $0.00 | -$43.22M | -$42.81M | -0.86 |
| 2020 | $0.00 | -$185.00K | -$17.19M | -$17.05M | -0.35 |